The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's Disease

While animal experiments have contributed much to our understanding of the mechanisms of Alzheimer's disease (AD), their value in predicting the effectiveness of treatment strategies in clinical trials has remained controversial. The disparity between the results obtained in animal models and c...

Full description

Bibliographic Details
Main Authors: Radmila Mileusnic, Steven Rose
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:International Journal of Alzheimer's Disease
Online Access:http://dx.doi.org/10.4061/2010/180734
id doaj-9d78ecc7914b4c05857225e2f46bdc94
record_format Article
spelling doaj-9d78ecc7914b4c05857225e2f46bdc942020-11-25T01:02:47ZengHindawi LimitedInternational Journal of Alzheimer's Disease2090-02522010-01-01201010.4061/2010/180734180734The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's DiseaseRadmila Mileusnic0Steven Rose1Department of Life Sciences, Faculty of Sciences, The Open University, Milton Keynes, MK7 6AA, UKDepartment of Life Sciences, Faculty of Sciences, The Open University, Milton Keynes, MK7 6AA, UKWhile animal experiments have contributed much to our understanding of the mechanisms of Alzheimer's disease (AD), their value in predicting the effectiveness of treatment strategies in clinical trials has remained controversial. The disparity between the results obtained in animal models and clinical trials may in part be explained by limitations of the models and species-specific differences. We propose that one trial passive avoidance in the day-old chick is a useful system to study AD because of the close sequence homologies of chick and human amyloid precursor protein (APP). In the chick, APP is essential for memory consolidation, and disrupting its synthesis or structure results in amnesia. RER, a tripeptide sequence corresponding to part of the growth domain of APP, can restore memory loss and act as a cognitive enhancer. We suggest that RER and its homologues may form the basis for potential pharmacological protection against memory loss in AD.http://dx.doi.org/10.4061/2010/180734
collection DOAJ
language English
format Article
sources DOAJ
author Radmila Mileusnic
Steven Rose
spellingShingle Radmila Mileusnic
Steven Rose
The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's Disease
International Journal of Alzheimer's Disease
author_facet Radmila Mileusnic
Steven Rose
author_sort Radmila Mileusnic
title The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's Disease
title_short The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's Disease
title_full The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's Disease
title_fullStr The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's Disease
title_full_unstemmed The Chick as a Model for the Study of the Cellular Mechanisms and Potential Therapies for Alzheimer's Disease
title_sort chick as a model for the study of the cellular mechanisms and potential therapies for alzheimer's disease
publisher Hindawi Limited
series International Journal of Alzheimer's Disease
issn 2090-0252
publishDate 2010-01-01
description While animal experiments have contributed much to our understanding of the mechanisms of Alzheimer's disease (AD), their value in predicting the effectiveness of treatment strategies in clinical trials has remained controversial. The disparity between the results obtained in animal models and clinical trials may in part be explained by limitations of the models and species-specific differences. We propose that one trial passive avoidance in the day-old chick is a useful system to study AD because of the close sequence homologies of chick and human amyloid precursor protein (APP). In the chick, APP is essential for memory consolidation, and disrupting its synthesis or structure results in amnesia. RER, a tripeptide sequence corresponding to part of the growth domain of APP, can restore memory loss and act as a cognitive enhancer. We suggest that RER and its homologues may form the basis for potential pharmacological protection against memory loss in AD.
url http://dx.doi.org/10.4061/2010/180734
work_keys_str_mv AT radmilamileusnic thechickasamodelforthestudyofthecellularmechanismsandpotentialtherapiesforalzheimersdisease
AT stevenrose thechickasamodelforthestudyofthecellularmechanismsandpotentialtherapiesforalzheimersdisease
AT radmilamileusnic chickasamodelforthestudyofthecellularmechanismsandpotentialtherapiesforalzheimersdisease
AT stevenrose chickasamodelforthestudyofthecellularmechanismsandpotentialtherapiesforalzheimersdisease
_version_ 1725203618874785792